Greenlane Stock Forecast, Price & News

Greenlane (NASDAQ:GNLN) Frequently Asked Questions

Is Greenlane a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Greenlane stock.
View analyst ratings for Greenlane or view top-rated stocks.

How has Greenlane's stock price been impacted by Coronavirus?

Greenlane's stock was trading at $1.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GNLN stock has decreased by 49.8% and is now trading at $0.7224.
View which stocks have been most impacted by COVID-19.

When is Greenlane's next earnings date?

Greenlane is scheduled to release its next quarterly earnings announcement on Wednesday, March 30th 2022.
View our earnings forecast for Greenlane.

How were Greenlane's earnings last quarter?

Greenlane Holdings, Inc. (NASDAQ:GNLN) announced its quarterly earnings data on Monday, November, 15th. The company reported ($0.23) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.16. The business had revenue of $41.31 million for the quarter, compared to analysts' expectations of $40.31 million. Greenlane had a negative net margin of 18.52% and a negative trailing twelve-month return on equity of 26.06%. During the same quarter in the previous year, the firm earned ($0.46) EPS.
View Greenlane's earnings history.

What guidance has Greenlane issued on next quarter's earnings?

Greenlane updated its third quarter 2021 earnings guidance on Thursday, November, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $40 million-$41 million, compared to the consensus revenue estimate of $45.99 million.

What price target have analysts set for GNLN?

4 analysts have issued twelve-month price targets for Greenlane's stock. Their forecasts range from $5.00 to $6.30. On average, they expect Greenlane's share price to reach $5.83 in the next year. This suggests a possible upside of 706.3% from the stock's current price.
View analysts' price targets for Greenlane or view top-rated stocks among Wall Street analysts.

Who are Greenlane's key executives?

Greenlane's management team includes the following people:

• Nicholas Kovacevich, Chief Executive Officer & Director
• Rodrigo de Oliveira, Chief Operating Officer
• William E. Mote, Chief Financial Officer (LinkedIn Profile)
• Adam Schoenfeld, Director & Chief Marketing Officer (LinkedIn Profile)
• Kathy Ziegler, General Manager-Supply & Packaging

What is 's approval rating as Greenlane's CEO?

2 employees have rated Greenlane CEO on Glassdoor.com. has an approval rating of 100% among Greenlane's employees. This puts in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Greenlane's key competitors?

Some companies that are related to Greenlane include Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY), Spring Valley Acquisition (SV), Cuisine Solutions (CUSI), Limoneira (LMNR), Alico (ALCO), Lee Enterprises (LEE), Exlites Holdings International (EXHI), Blue Apron (APRN), Crimson Wine Group (CWGL), AMAYA Global (AYAG), Tuesday Morning (TUEM), Local Bounti (LOCL), Real Good Food (RGF), TAAT Global Alternatives (TOBAF) and Cadiz (CDZI).
View all of GNLN's competitors.

What other stocks do shareholders of Greenlane own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include KushCo (KSHB), OrganiGram (OGI), Enerplus (ERF), Matinas BioPharma (MTNB), Supreme Cannabis (SPRWF), ADMA Biologics (ADMA), EnLink Midstream (ENLC), Gran Tierra Energy (GTE), MariMed (MRMD) and Novan (NOVN).

When did Greenlane IPO?

(GNLN) raised $80 million in an initial public offering (IPO) on Thursday, April 18th 2019. The company issued 5,300,000 shares at $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity served as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

What is Greenlane's stock symbol?

Greenlane trades on the NASDAQ under the ticker symbol "GNLN."

Who are Greenlane's major shareholders?

Greenlane's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FNY Investment Advisers LLC (0.03%). Company insiders that own Greenlane stock include Aaron Locascio, Adam Schoenfeld and William E Mote Jr.
View institutional ownership trends for Greenlane.

Which institutional investors are buying Greenlane stock?

GNLN stock was acquired by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC.
View insider buying and selling activity for Greenlane or or view top insider-buying stocks.

How do I buy shares of Greenlane?

Shares of GNLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Greenlane's stock price today?

One share of GNLN stock can currently be purchased for approximately $0.72.

How much money does Greenlane make?

Greenlane has a market capitalization of $73.88 million and generates $138.30 million in revenue each year. The company earns $-14.52 million in net income (profit) each year or ($1.11) on an earnings per share basis.

How many employees does Greenlane have?

Greenlane employs 264 workers across the globe.

What is Greenlane's official website?

The official website for Greenlane is www.gnln.com.

Where are Greenlane's headquarters?

Greenlane is headquartered at 1095 BROKEN SOUND PARKWAY SUITE 300, BOCA RATON FL, 33487.

How can I contact Greenlane?

Greenlane's mailing address is 1095 BROKEN SOUND PARKWAY SUITE 300, BOCA RATON FL, 33487. The company can be reached via phone at (877) 292-7660 or via email at [email protected].